US Tech 100

19,562.00

-0.09%

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

Home
Investing
Stocks
USA
NYSE
Aventis New Ads (AVE)
Aventis New Ads (AVE) News

AVE

Aventis (AVE)

Aventis New Ads

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NYSE:AVE

1 2 Next >>

Date	Time	Source	Headline	Symbol	Company
10/15/2004	4:03PM	PR Newswire (US)	Rhone-Poulenc Overseas Limited Announces Redemption of All Outstanding Cumulative Guaranteed Preference Shares, Series A	NYSE:AVE	Aventis New Ads
10/04/2004	2:44PM	PR Newswire (US)	Aventis Ships 30 Million Doses of Influenza Vaccine to Health-Care Providers	NYSE:AVE	Aventis New Ads
09/22/2004	4:23PM	PR Newswire (US)	Advisory Panel Recommends FDA Licensure of Aventis' Menactra(TM) Vaccine for Protection Against Meningococcal Disease	NYSE:AVE	Aventis New Ads
09/21/2004	8:30AM	PR Newswire (US)	Aventis Named to List of Top 100 Companies for Working Mothers	TSXV:AVE
09/16/2004	2:00AM	PR Newswire (US)	The sanofi-aventis Group Thanks Its Team Members and Shareholders and Launches Its New Visual Identity	TSXV:AVE
09/14/2004	8:30AM	PR Newswire (US)	Coley Pharmaceutical Group Receives Payment From Aventis for Clinical Milestone in Collaboration on Allergic Respiratory Disease	NYSE:AVE	Aventis New Ads
08/19/2004	8:00AM	PR Newswire (US)	FDA Approves Taxotere(R) for the Treatment of Women with Early Stage Breast Cancer	NYSE:AVE	Aventis New Ads
08/11/2004	10:39AM	PR Newswire (US)	Aventis Submits Application for FDA Licensure of ADACEL(TM) Vaccine for Prevention of Tetanus, Diphtheria and Pertussis in Adole	NYSE:AVE	Aventis New Ads
08/05/2004	7:02PM	PR Newswire (US)	Ventiv Health Announces Sales and Marketing Agreement with Aventis	NYSE:AVE	Aventis New Ads
08/03/2004	1:58PM	PR Newswire (US)	FDA Approves Sculptra(TM) (Injectable Poly-L-Lactic Acid)	NYSE:AVE	Aventis New Ads
07/28/2004	2:31PM	PR Newswire (US)	Aventis Reports Second-Quarter and First-Half Results for 2004	NYSE:AVE	Aventis New Ads
07/27/2004	10:29AM	PR Newswire (US)	Aventis to Move Forward With Reissuance Process for Contested Lovenox Patent	TSXV:AVE
07/07/2004	8:00AM	PR Newswire (US)	New Data Confirm Lovenox(R) is an Effective Antithrombotic for Treatment of Acute Coronary Syndromes	TSXV:AVE
06/23/2004	9:50AM	PR Newswire (US)	Sanofi-Synthelabo's Offer for Aventis Expiration Date of Offers	TSXV:AVE
06/14/2004	10:43AM	PR Newswire (US)	Sanofi-Synthelabo's Offer for Aventis; Adjustment of Offer Terms on Approval of Aventis Dividend	TSXV:AVE
06/07/2004	12:00PM	PR Newswire (US)	Two Landmark Studies Show That Taxotere(R) Significantly Improves Survival in Men With Prostate Cancer	NYSE:AVE	Aventis New Ads
06/05/2004	9:00AM	PR Newswire (US)	Investigators Report Taxotere(R) Offers Significant Survival Benefits for Head and Neck Cancer Patients	NYSE:AVE	Aventis New Ads
06/01/2004	2:40PM	PR Newswire (US)	Sanofi-Synthelabo's Offer for Aventis Expiration Date of Offers	TSXV:AVE
05/28/2004	12:00PM	PR Newswire (US)	Genta and Aventis Announce Termination of Genasense(TM) Expanded Access Program in Melanoma	NYSE:AVE	Aventis New Ads
05/27/2004	2:00AM	PR Newswire (US)	Aventis and U.S. NIH Enter Into Pandemic Influenza Vaccine Agreement	TSXV:AVE
05/26/2004	10:05AM	PR Newswire (US)	Sanofi-Synthelabo's Offer for Aventis U.S. Offer Extended to Wednesday, June 30, 2004	TSXV:AVE
05/26/2004	8:00AM	PR Newswire (US)	Two Landmark Studies of Taxotere(R) in Prostate Cancer Highlighted in American Society of Clinical Oncology Plenary Session	NYSE:AVE	Aventis New Ads
05/23/2004	12:15PM	PR Newswire (US)	Data Show Once-Daily Alvesco(R) (ciclesonide) Has No Effect on HPA-Axis Function in Asthma Patients	TSXV:AVE
05/23/2004	12:15PM	PR Newswire (US)	Surveillance Study Finds Newly-Approved Antibiotic KETEK(R) (telithromycin) Tablets 99% Effective In Vitro Against Streptococcus	TSXV:AVE
05/19/2004	2:39PM	PR Newswire (US)	Aventis Receives FDA Approval for Taxotere(R) in Prostate Cancer	NYSE:AVE	Aventis New Ads
05/18/2004	8:01AM	PR Newswire (US)	Aventis Receives Priority Review Designation for the Registrational Application to Support the Use of Taxotere(R) in Women with	TSXV:AVE
05/05/2004	10:12AM	PR Newswire (US)	Sanofi-Synthelabo's Offer for Aventis	TSXV:AVE
05/03/2004	2:52PM	PR Newswire (US)	FDA Advisory Committee Reviews Genasense(TM) for Use in Advanced Melanoma	NYSE:AVE	Aventis New Ads
04/30/2004	2:55PM	PR Newswire (US)	Aventis Pasteur Statement on New Influenza Immunization Recommendations for Infants, Young Children and Their Close Contacts	TSXV:AVE
04/29/2004	1:03PM	PR Newswire (US)	Aventis Reports First-Quarter Results for 2004	TSXV:AVE